John H. Rex
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 148
-
- Antibiotic Use and Resistance 35
- Co-authors
- Michael A. Pfaller (26 shared papers)Luis Ostrosky‐Zeichner (34 shared papers)Thomas J. Walsh (24 shared papers)Peter G. Pappas (16 shared papers)John Ernest Edwards (10 shared papers)Scott G. Filler (5 shared papers)William E. Dismukes (8 shared papers)Victor L. Paetznick (24 shared papers)
- Journals
- Clinical Infectious Diseases (46 papers)Antimicrobial Agents and Chemotherapy (33 papers)Journal of Clinical Microbiology (25 papers)British Journal of Sociology (13 papers)Medical Mycology (10 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
John H. Rex
338 papers receiving 32.8k citations
John H. Rex's Hit Papers
Peers
Comparison fields: 5 of 218
- Infectious Diseases 21.7k
- Applied Microbiology and Biotechnology 1.8k
- Epidemiology 15.7k
- Molecular Medicine 1.5k
- Small Animals 1.9k
Countries citing papers authored by John H. Rex
This map shows the geographic impact of John H. Rex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Rex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Rex more than expected).
Fields of papers citing papers by John H. Rex
This network shows the impact of papers produced by John H. Rex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Rex. The network helps show where John H. Rex may publish in the future.
Co-authors
The 25 scholars most cited alongside John H. Rex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 364 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2009 | 2621 |
| 2 | Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus Hit paper breakdown → | 2002 | 2058 |
| 3 | Guidelines for Treatment of Candidiasis Hit paper breakdown → | 2004 | 1189 |
| 4 | A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia Hit paper breakdown → | 1994 | 900 |
| 5 | Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard Hit paper breakdown → | 2008 | 891 |
| 6 | Resistance of Candida species to fluconazole Hit paper breakdown → | 1995 | 796 |
| 7 | Practice Guidelines for the Treatment of Candidiasis Hit paper breakdown → | 2000 | 781 |
| 8 | Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections Hit paper breakdown → | 1997 | 770 |
| 9 | A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric Patients Hit paper breakdown → | 2003 | 713 |
| 10 | Alternatives to antibiotics—a pipeline portfolio review Hit paper breakdown → | 2016 | 706 |
| 11 | Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials Hit paper breakdown → | 2012 | 669 |
| 12 | Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard Hit paper breakdown → | 2008 | 600 |
| 13 | Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans Hit paper breakdown → | 2005 | 574 |
| 14 | 2004 | 538 | |
| 15 | 2004 | 484 | |
| 16 | Social Behaviour, Its Elementary Forms Hit paper breakdown → | 1962 | 459 |
| 17 | 2003 | 452 | |
| 18 | 2005 | 451 | |
| 19 | 2003 | 426 | |
| 20 | 2001 | 370 |
About John H. Rex
John H. Rex is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Epidemiology, Molecular Medicine and Pharmacology, having authored 364 papers that have together received 35.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (148 papers), Fungal Infections and Studies (83 papers), Antibiotic Use and Resistance (35 papers), Nail Diseases and Treatments (29 papers), Plant Pathogens and Fungal Diseases (27 papers), Antibiotic Resistance in Bacteria (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Bacterial Identification and Susceptibility Testing (16 papers). The work is most often cited by research in Infectious Diseases (21.7k citations), Applied Microbiology and Biotechnology (1.8k citations), Epidemiology (15.7k citations), Molecular Medicine (1.5k citations) and Small Animals (1.9k citations). John H. Rex has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Michael A. Pfaller, Luis Ostrosky‐Zeichner, Thomas J. Walsh, Peter G. Pappas, John Ernest Edwards, Scott G. Filler, William E. Dismukes, Victor L. Paetznick, Mario Lozano‐Chiu and Bart Jan Kullberg. Their work appears in journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, British Journal of Sociology and Medical Mycology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.